Register entry
JANSSEN THERAPEUTICS DIV JANSSEN PRODUCTS LP
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 4
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
4| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7498343 | SIRTURObedaquiline fumarate | substance, product | Dec 2026 |
| 8546428 | SIRTURObedaquiline fumarate | substance, product | Mar 2029 |
| Product | Exclusivity | Until |
|---|---|---|
| SIRTUROBEDAQUILINE FUMARATE | NPP New patient population | Jul 2028 |
Enquiry
Common questions
- Is JANSSEN THERAPEUTICS DIV JANSSEN PRODUCTS LP FDA approved?
- JANSSEN THERAPEUTICS DIV JANSSEN PRODUCTS LP holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.